• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Heat Biologics, Inc. (HTBX)

    0.71 Down 0.09(11.25%) Jun 24, 4:00PM EDT
    ProfileGet Profile for:
    Heat Biologics, Inc.
    801 Capitola Drive
    Durham, NC 27713
    United States - Map
    Phone: 919-240-7133
    Website: http://www.heatbio.com

    Index Membership:N/A
    Full Time Employees:27

    Business Summary 

    Heat Biologics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel allogeneic off-the-shelf cellular therapeutic vaccines for a range of cancers and infectious diseases in the United States. The company develops its products based on T cell-stimulating platform technologies, including immune pan-antigen cytotoxic therapy, a platform technology designed to educate and stimulate the immune system against specific disease targets, such as cancer cells; and combination pan-antigen cytotoxic therapy, a platform technology that combines a pan-antigen T cell activating vaccine and a T cell co-stimulator in a single product. Its product candidates include viagenpumatucel-L (HS-110) that is in Phase 2 clinical trials for the treatment of non-small cell lung cancer; and vesigenurtacel-L (HS-410), which is in Phase 1b clinical trials for the treatment of non-muscle invasive bladder cancer. The company was founded in 2008 and is based in Durham, North Carolina.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Heat Biologics, Inc.

    Key Executives 
    Mr. Jeffrey Alan Wolf J.D., 53
    Founder, Chairman, Chief Exec. Officer, Pres and Treasurer
    Dr. Taylor H. Schreiber M.D., Ph.D., 36
    Chief Scientific Officer
    Dr. Melissa Price Ph.D., 42
    VP of Product Devel.
    Ms. Ann A. Rosar , 64
    VP of Fin., Corp. Sec. and Controller
    Dr. Justin Stebbing M.D., M.A. FRCP FRC Path Ph.D.,
    Chief Medical Advisor and Member of Scientific & Clinical Advisory Board
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders